Journal article
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Cancers, Vol.14(1), p.206
01/01/2022
DOI: 10.3390/cancers14010206
PMCID: PMC8744660
PMID: 35008370
Abstract
The oncogenic role of estrogen receptor (ER) signaling in breast cancer has long been established. Interaction of estrogen with estrogen receptor (ER) in the nucleus activates genomic pathways of estrogen signaling. In contrast, estrogen interaction with the cell membrane-bound G-protein-coupled estrogen receptor (GPER) activates the rapid receptor-mediated signaling transduction cascades. Aberrant estrogen signaling enhances mammary epithelial cell proliferation, survival, and angiogenesis, hence is an important step towards breast cancer initiation and progression. Meanwhile, a growing number of studies also provide evidence for estrogen's pro- or anti-inflammatory roles. As other articles in this issue cover classic ER and GPER signaling mediated by estrogen, this review will discuss the crucial mechanisms by which estrogen signaling influences chronic inflammation and how that is involved in breast cancer. Xenoestrogens acquired from plant diet or exposure to industrial products constantly interact with and alter innate estrogen signaling at various levels. As such, they can modulate chronic inflammation and breast cancer development. Natural xenoestrogens generally have anti-inflammatory properties, which is consistent with their chemoprotective role in breast cancer. In contrast, synthetic xenoestrogens are proinflammatory and carcinogenic compounds that can increase the risk of breast cancer. This article also highlights important xenoestrogens with a particular focus on their role in inflammation and breast cancer. Improved understanding of the complex relationship between estrogens, inflammation, and breast cancer will guide clinical research on agents that could advance breast cancer prevention and therapy.
Details
- Title: Subtitle
- Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
- Creators
- Chandra K. Maharjan - Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USAJiao Mo - Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USALei Wang - Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USAMyung-Chul Kim - Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USASameul WangNicholas Borcherding - Washington University in St. LouisPraveen Vikas - University of Iowa, Internal MedicineWeizhou Zhang - Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA
- Resource Type
- Journal article
- Publication Details
- Cancers, Vol.14(1), p.206
- DOI
- 10.3390/cancers14010206
- PMID
- 35008370
- PMCID
- PMC8744660
- NLM abbreviation
- Cancers (Basel)
- ISSN
- 2072-6694
- eISSN
- 2072-6694
- Publisher
- Mdpi
- Number of pages
- 31
- Grant note
- Dr. and Mrs. James Robert Spenser Family BC180227; BC200100 / DOD/CDMRP; United States Department of Defense CA200673; CA203834; CA260239 / NIH; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Language
- English
- Date published
- 01/01/2022
- Academic Unit
- Dermatology; Hematology, Oncology, and Blood & Marrow Transplantation; Radiation Oncology; Neuroscience and Pharmacology; Internal Medicine
- Record Identifier
- 9984359817302771
Metrics
16 Record Views